AustralianSuper’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137M | Sell |
8,151,743
-410,479
| -5% | -$6.88M | 0.69% | 35 |
|
|
2025
Q1 | $132M | Sell |
8,562,222
-660,473
| -7% | -$10.2M | 0.74% | 34 |
|
|
2024
Q4 | $203M | Buy |
9,222,695
+1,329,319
| +17% | +$29.3M | 0.96% | 23 |
|
|
2024
Q3 | $142M | Sell |
7,893,376
-611,726
| -7% | -$11M | 0.71% | 45 |
|
|
2024
Q2 | $138M | Sell |
8,505,102
-1,606,968
| -16% | -$26.1M | 0.8% | 47 |
|
|
2024
Q1 | $141M | Buy |
10,112,070
+1,073,000
| +12% | +$14.9M | 0.82% | 43 |
|
|
2023
Q4 | $94.4M | Buy |
9,039,070
+1,431,671
| +19% | +$14.9M | 0.57% | 50 |
|
|
2023
Q3 | $77.6M | Buy |
7,607,399
+664,152
| +10% | +$6.77M | 0.5% | 62 |
|
|
2023
Q2 | $52.3M | Buy |
6,943,247
+4,523,700
| +187% | +$34.1M | 0.33% | 77 |
|
|
2023
Q1 | $21.4M | Hold |
2,419,547
| – | – | 0.13% | 104 |
|
|
2022
Q4 | $23.1M | Sell |
2,419,547
-437,442
| -15% | -$4.17M | 0.15% | 101 |
|
|
2022
Q3 | $23.1K | Buy |
2,856,989
+895,242
| +46% | +$7.23K | 0.16% | 94 |
|
|
2022
Q2 | $14.8K | Sell |
1,961,747
-702,819
| -26% | -$5.29K | 0.09% | 146 |
|
|
2022
Q1 | $25K | Buy |
2,664,566
+355,662
| +15% | +$3.34K | 0.14% | 107 |
|
|
2021
Q4 | $19.4K | Sell |
2,308,904
-126,851
| -5% | -$1.06K | 0.1% | 127 |
|
|
2021
Q3 | $23.7M | Sell |
2,435,755
-424,038
| -15% | -$4.13M | 0.15% | 97 |
|
|
2021
Q2 | $28.3M | Buy |
2,859,793
+887,092
| +45% | +$8.78M | 0.2% | 78 |
|
|
2021
Q1 | $22.8M | Buy |
1,972,701
+1,524,197
| +340% | +$17.6M | 0.18% | 83 |
|
|
2020
Q4 | $4.33M | Buy |
448,504
+227,592
| +103% | +$2.2M | 0.03% | 113 |
|
|
2020
Q3 | $1.99M | Buy |
+220,912
| New | +$1.99M | 0.02% | 122 |
|